Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15815 articles
Body mass index (BMI) trajectories and risk of colorectal cancer in the PLCO cohort.
Obesity BMI trajectories over lifespan lead to increased CRC risk.
»
11/22/17
Extracellular gamma-synuclein promotes tumor cell motility by activating β1 integrin-focal adhesion kinase signaling pathway and increasing matrix metalloproteinase-24, -2 protein secretion
Protease activity of MMP-2 in the CM of HCT116 cells increased by treatment with SNCG.
»
06/15/18
ALDH1A inhibition sensitizes colon cancer cells to chemotherapy
Inhibition of proliferation of subcutaneous xenografts in comparison to control cells.
»
06/15/18
Impact of pre-diagnostic triglycerides and HDL-cholesterol on breast cancer recurrence and survival by breast cancer subtypes
Pre-diagnostic triglyceride level inversely associated with overall mortality.
»
06/15/18
Expression of the glucagon-like peptide-1 receptor and its role in regulating autophagy in endometrial cancer
Higher GLP-1R expression significantly correlated with better progression-free survival.
»
06/15/18
Quercetin inhibits prostate cancer by attenuating cell survival and inhibiting anti-apoptotic pathways
PCa cells with mutated p53 (DU-145) showed significant reduction in activation of pro-survival Akt pathway.
»
06/14/18
AAED1 modulates proliferation and glycolysis in gastric cancer.
Silencing of AAED1 inhibited cancer cell proliferation in vitro.
»
12/13/17
Circulating miRNAs in blood and urine as diagnostic and prognostic biomarkers for bladder cancer: an update in 2017.
Insufficient data currently to prove usefulness of circulating miRNAs as robust biomarkers for BC.
»
06/14/18
Simultaneous blockade of IL-6 and CCL5 signaling for synergistic inhibition of triple-negative breast cancer growth and metastasis
Combination of maraviroc and cMR16-1 caused significant reduction of TNBC tumor growth.
»
06/14/18
Licofelone enhances the efficacy of paclitaxel in ovarian cancer by reversing drug resistance and tumor stem-like properties.
Need to clinically evaluate licofelone in combination with front-line chemotherapy.
»
05/29/18
< Prev
Next >